<--- Back to Details
First PageDocument Content
Pharmacology / Clinical research / Epidemiology / Rare disease / Orphan drug / European Medicines Agency / European Organization for Rare Diseases / Pharmaceutical industry / Expanded access / Health / Medicine / Science
Date: 2013-10-09 08:43:48
Pharmacology
Clinical research
Epidemiology
Rare disease
Orphan drug
European Medicines Agency
European Organization for Rare Diseases
Pharmaceutical industry
Expanded access
Health
Medicine
Science

Add to Reading List

Source URL: ec.europa.eu

Download Document from Source Website

File Size: 53,70 KB

Share Document on Facebook

Similar Documents

The European Agency for the Evaluation of Medicinal Products Veterinary Medicines and Inspections EMEA/CVMPFINAL COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

DocID: 1vrLd - View Document

7 May 2018 EMAHuman Medicines Research and Development Support Division European Medicines Agency Guidance for applicants seeking access to PRIME scheme

DocID: 1vlIp - View Document

The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Human Use London, 23 January 2003 CPMP/SWP

DocID: 1ucvu - View Document

2 March 2016 EMAExternal guidance on the implementation of the European Medicines Agency policy on the publication of clinical data for medicinal products for human use

DocID: 1sVev - View Document

European Medicines Agency: Celebrating 20 years

DocID: 1sUY9 - View Document